ChemoCentryx
CCXI
#3713
Rank
HK$29.28 B
Marketcap
HK$407.12
Share price
0.00%
Change (1 day)
34.97%
Change (1 year)

EPS for ChemoCentryx (CCXI)

EPS in 2022 (TTM): -HK$14.78

According to ChemoCentryx's latest financial reports the company's current EPS (TTM) is -HK$14.80. In 2021 the company made an earnings per share (EPS) of -HK$14.80 a decrease over its 2020 EPS that were of -HK$6.34.

EPS history for ChemoCentryx from 2012 to 2022

Annual EPS

Year EPS Change
2022 (TTM)-HK$14.78-0.17%
2021-HK$14.80133.33%
2020-HK$6.34-16.49%
2019-HK$7.6027.63%
2018-HK$5.95-305.41%
2017HK$2.90-142.53%
2016-HK$6.81-19.44%
2015-HK$8.46-0%
2014-HK$8.4613.68%
2013-HK$7.44-16.67%
2012-HK$8.93

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Johnson & Johnson
JNJ
HK$87.22-689.34%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
HK$10.65-171.96%๐Ÿ‡บ๐Ÿ‡ธ USA
AbbVie
ABBV
HK$18.73-226.54%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
HK$112.22-858.20%๐Ÿ‡บ๐Ÿ‡ธ USA
Biogen
BIIB
HK$69.15-567.20%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
HK$57.25-486.79%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
HK$27.09-283.07%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
HK$29.51-299.37%๐Ÿ‡ฌ๐Ÿ‡ง UK
Teva Pharmaceutical Industries
TEVA
HK$9.71-165.61%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel